An Observational Study of Patients With Chronic Liver Disease

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

NCT04550481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

NCT02932449 ·Status: COMPLETED

Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)

NCT03248882 ·Status: COMPLETED ·Phase: PHASE2

An Follow-Up Study of Liver Cirrhosis

NCT03472742 ·Status: COMPLETED

A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.

NCT05857644 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

NCT05768334 ·Status: COMPLETED ·Phase: PHASE3

Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

NCT00298714 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

NCT06773221 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.

NCT03776175 ·Status: COMPLETED ·Phase: PHASE2

Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease

NCT05754385 ·Status: COMPLETED ·Phase: NA

A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver Dysfunction

NCT05478603 ·Status: COMPLETED ·Phase: PHASE1

Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study

NCT05036031 ·Status: UNKNOWN

Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease

NCT07242222 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease

NCT06797011 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

NCT06750276 ·Status: COMPLETED ·Phase: PHASE2

Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure Study

NCT02457637 ·Status: COMPLETED

2-Week Study In People With Nonalcoholic Fatty Liver Disease

NCT03513588 ·Status: COMPLETED ·Phase: PHASE1

Tissue Models for Liver Disease

NCT05255042 ·Status: COMPLETED

A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

NCT05917938 ·Status: COMPLETED ·Phase: PHASE1

Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD

NCT06321211 ·Status: COMPLETED

Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.

NCT04579874 ·Status: COMPLETED ·Phase: NA

Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation

NCT05256979 ·Status: ACTIVE_NOT_RECRUITING

Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)

NCT05292911 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction

NCT00550849 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers

NCT00856713 ·Status: COMPLETED ·Phase: PHASE1